Status:

COMPLETED

Comparison Between Different Types of Oxygen Treatment Following Traumatic Brain Injury

Lead Sponsor:

Hennepin Healthcare Research Institute

Conditions:

Traumatic Brain Injury

Eligibility:

All Genders

16-65 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to study the effects of EARLY (no more than 24 four hours from injury) administration of extra amounts of oxygen on traumatic brain injury.

Detailed Description

Brain injury continues to be a major cause of death and disability throughout the world. Our investigations of hyperbaric oxygen treatment (HBOT) indicate that it is a relatively safe treatment that h...

Eligibility Criteria

Inclusion

  • All closed head trauma victims with GCS score \< 8, when no effects from paralytics, sedation, alcohol and/or street drugs are present.
  • Informed consent obtained.
  • Entry into the study within 24 hours after injury.
  • If a patient enters the hospital with a mild or moderate brain injury and subsequently deteriorates to a GCS \< 8 within 48 hours of admission, the patient is considered a candidate for entry into the study.
  • CT scan score \> II in accordance with the classification system of the Traumatic Coma Data Bank.

Exclusion

  • Consent could not be obtained.
  • Patients who are brain dead or close to brain death (fixed, dilated pupils).
  • Unstable pulmonary status requiring FiO2 of 50% or greater to maintain a PaO2 of 70 mm Hg or greater.
  • History of severe pulmonary disease, such as COPD or asthma.
  • Unstable fracture (spine, pelvis, femur, etc) preventing placement into the HBO chamber.
  • Patients placed in barbiturate coma during initial management due to the potential effect barbiturates have on cerebral metabolism.
  • Age range \< 16 years or \> 65 years.
  • Coagulopathy.
  • Pregnancy.
  • Severe mental retardation or prior severe head injury.
  • High velocity penetrating injury to the head,(e.g. gunshot wound).
  • Multiple organ failure.
  • Massive cerebral hemisphere or brainstem hematoma, stroke

Key Trial Info

Start Date :

November 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2008

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT00170352

Start Date

November 1 2002

End Date

November 1 2008

Last Update

August 28 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hennepin County Medical Center

Minneapolis, Minnesota, United States, 55415